FDA
approval
· 2015-06-17
FDA Approved: GYNAZOLE 1 — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
Summary
The FDA approved a supplemental application for GYNAZOLE 1 (butoconazole nitrate) from Padagis Israel Pharmaceuticals Ltd, for the treatment of vaginal candidia…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GYNAZOLE 1 (BUTOCONAZOLE NITRATE)